跳至主要内容
临床试验/NL-OMON49467
NL-OMON49467招募中不适用

Identifying motivational alterations associated with cancer-related fatigue: a longitudinal study in testicular cancer patients - Motivational aspects of cancer-related fatigue - LONG

Radboud Universitair Medisch Centrum0 个研究点目标入组 105 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • For all participants (healthy and patients):
  • Written informed consent
  • Age between 18 and 50 yrs
  • Sufficient command of the Dutch language (to answer questionnaires)
  • For all patients:
  • Unilateral orchiectomy
  • BEP or EP treatment regimen (for sugery+chemo group)
  • No patients who received radiotherapy because of non-comparable tumor-types
  • and treatment side-effects

排除标准

  • For all participants (healthy and patients):
  • Presence of acute infection or inflammation on day of testing (body
  • temperature >38)
  • Current use of prescribed psychotropic, pain or anti-inflammatory drugs
  • (history of) long-term (> 6 months) daily use of over-the-counter NSAIDs
  • (ibuproven, diclofenac, naproxen) (for patients: besides those used during
  • cancer-treatment)
  • Current use of over-the-counter corticosteroids, anti-histamic or
  • anti-inflammatory drugs (participants that use corticosteroid moistures or
  • hay-fever drugs are asked to not use it on the testing day)
  • Obesity (BMI>30)
  • (history of) metabolic disease (e.g. diabetes)
  • (history of) cardiovascular events
  • (history of) neurological or psychiatric symptoms/disease
  • (history of) chronic inflammatory disease (e.g. rheumatoid arthritis, Crohns
  • (history of) hypo/hyperthyroide
  • (history of) chronic pain (>6 months) (for patients before diagnosis)
  • (history of) chronic fatigue syndrome or fibromyalgia (for patients before
  • (history of) hypogonadism/ hormonal disturbance or suppletion (for patients
  • before diagnosis)
  • (history of) renal failure
  • For all patients
  • Patients who received radiotherapy because of non-comparable tumor-types and
  • treatment side-effects
  • For all healthy participants
  • Severe fatigue (CIS-fatigue <35)

研究者

相似试验